Supporting Innovation in Connecticut: A Partnership of Progress with Connecticut Innovations
By
Michael Astrachan
As a Connecticut-based company, we're not just located in the state; we are an integral part of its vibrant ecosystem of innovation and progress. Our pride in being a Connecticut company runs deep, fueled by the opportunities to collaborate with remarkable inventors, scientists, and entrepreneurs.
COVID Vaccine Animation goes Viral!
By
Michael Astrachan
The Vaccine Makers Project, a program of the Vaccine Education Center at Children’s Hospital of Philadelphia (VEC@CHOP) and Medical History Pictures (MHP) partnered up again with XVIVO to help develop two new animations, this time about how COVID-19 vaccines work. With the monumental task of helping people understand new information about COVID-19, we were honored and thrilled to put our passion for communicating science into these animation projects.
How COVID-19 mRNA Vaccines Work – Vaccine Makers Project
By
Michael Astrachan
In partnership with CHOP, VMP and Medical History Pictures, XVIVO has created a series of animations that bring to life the detailed processes of how the human immune system fights diseases at both the cellular and molecular levels with the help of vaccinations. In response to ever-evolving conditions within the current pandemic, we have just completed the first of two new videos that explain specifically how COVID-19 vaccines work to prevent the disease.
Reinforcing Tendon and Ligament Repair with BioBrace
By
Michael Astrachan
Biorez has pioneered the BioBrace, the first ‘biocomposite’ soft tissue scaffold engineered to both mechanically reinforce tendon and ligament repairs, and enhance healing through its unique material properties and open architecture.
Innovative Ocular Therapeutics
By
Michael Astrachan
Qlaris Bio is investigating a novel type of medicine to reduce the pressure inside the eye, with the hopes of providing a new and targeted option to people suffering from glaucoma. To help viewers understand how their investigational drug QLS-101 works, the first step was to make the complex anatomy of the eye more understandable and explain the variety of factors that regulate the pressure inside the eye under normal circumstances.
T Cell Engaging Therapies for Solid Tumor Cancers: The Maverick Approach
By
Michael Astrachan
XVIVO partnered with Maverick Therapeutics to create an animation that brought to life the mechanism of action behind their pioneering approach to solid tumor cancer immunotherapy.
Peering into the Brain: Neuralink’s brain-machine interface
By
Michael Astrachan
XVIVO was recently tasked with creating an animation that provides a 30,000-foot overview of neurophysiological signaling in the human brain to help the team at Neuralink describe the science that underpins their BMI device development.
Understanding the Science Behind Viruses Can Help You Get Through the Pandemic
By
Michael Astrachan
The beautiful thing about science is that once we understand how things work, we can then make intelligent decisions. There’s a lot of highly politicized and sometimes conflicting messaging floating around about the current COVID-19 pandemic raging across the globe. So we thought it would be timely to share with you some highly informative animations we have produced about the mechanisms of virus transmission and the capability of the human body’s immune system to fight back and protect us.
HILLEMAN – A PERILOUS QUEST TO SAVE THE WORLD’S CHILDREN
By
Michael Astrachan
Medical History Pictures together with Paul Offit produced HILLEMAN – A Perilous Quest to Save the World’s Children, a feature-length documentary about the life and legacy of this legendary scientist. The animation you see in this film was done by XVIVO and was an incredible project to be part of.
CONDUIT™ Interbody Platform
By
Michael Astrachan
XVIVO and DePuy Synthes (a Johnson & Johnson company) recently partnered on an animation of their CONDUIT™ Interbody medical devices to help healthcare providers understand the level of engineering and detail that is embedded in the devices, with the goal of optimizing efficacy.